Alpha lipoic acid & acetyl l carnitine are often stacked for mitochondrial energy and nerve support. See doses, evidence, and safety in one guide.
Alpha lipoic acid (ALA) and acetyl L-carnitine (ALCAR) are two over-the-counter supplements that people frequently take together because both support mitochondrial energy production. ALA is an antioxidant that also acts as a cofactor for enzymes that turn food into cellular energy, while ALCAR carries fatty acids into the mitochondria to be burned as fuel. Neither is FDA-approved to treat or prevent any disease, and human evidence for the combination is limited and mixed.
Most people searching for acetyl l carnitine and alpha lipoic acid want to know whether the pair is worth taking for energy, memory, or nerve health. The short answer: both are generally well tolerated at typical doses, but benefits in healthy adults are modest, and the strongest clinical data belong to ALA alone rather than the combination.
What Each Supplement Does
ALA and ALCAR act on different parts of the same system, so each one has its own evidence base, typical dose, and side-effect profile.
Alpha lipoic acid (ALA)
- Role: A sulfur-containing antioxidant that also serves as a cofactor for mitochondrial enzymes such as pyruvate dehydrogenase.
- Forms: The natural R-alpha lipoic acid form is more biologically active than the synthetic S- form; most products are a 50/50 racemic mix.
- Absorption: Gut absorption is poor and variable, and taking it on an empty stomach improves uptake.
- Food sources: Small amounts appear in spinach, broccoli, yeast, organ meats, and potatoes.
Acetyl L-carnitine (ALCAR)
- Role: An acetylated form of L-carnitine that shuttles long-chain fatty acids into mitochondria for beta-oxidation and supplies acetyl groups involved in neurotransmitter production.
- Blood-brain barrier: ALCAR crosses into the brain more readily than plain L-carnitine, which is why cognition studies tend to use it.
- Food sources: Red meat and dairy are the main dietary sources, and vegetarians generally have lower carnitine stores.
Why People Combine Them
Stacking the two is based on the idea that mitochondrial decline involves both oxidative stress and impaired fuel transport. Animal research from the early 2000s found that aged rats given ALA plus ALCAR performed better on memory tasks than rats given either compound alone.
Human trials have not reproduced that result as clearly. Research on alpha lipoic acid with acetyl l carnitine has focused mainly on memory, nerve pain, and age-related fatigue, and findings have been inconsistent across studies.
ALA vs. ALCAR at a Glance
| Feature | Alpha lipoic acid (ALA) | Acetyl L-carnitine (ALCAR) |
|---|---|---|
| Primary role | Antioxidant and mitochondrial enzyme cofactor | Fatty-acid transport into mitochondria |
| Best-studied use | Diabetic peripheral neuropathy | Cognitive complaints and carnitine deficiency |
| Typical study doses | 600 to 1,800 mg per day | 1,000 to 2,000 mg per day |
| Common forms | R-ALA, racemic ALA, sodium R-lipoate | ALCAR (acetyl-L-carnitine HCl) |
| Common side effects | Nausea, heartburn, headache, low blood sugar | Nausea, restlessness, mild GI upset |
| Regulatory status (US) | Dietary supplement; not FDA-approved as a drug | Dietary supplement; not FDA-approved as a drug |
What the Research Suggests
Cognitive decline and memory
Small, short trials have tested acetyl-l-carnitine and alpha-lipoic acid in people with mild Alzheimer's disease and age-related memory complaints, usually at 600 to 1,000 mg of ALA and 1,000 to 2,000 mg of ALCAR daily. Some studies reported slower cognitive decline, while others found no meaningful difference from placebo. The trials were small, and none were large enough to change clinical guidelines.
Diabetic neuropathy
ALA has the strongest evidence of the two. A 600 mg intravenous dose of alpha lipoic acid is approved in Germany for symptomatic diabetic peripheral neuropathy, but it is not approved for that use in the United States. Oral ALA has shown modest pain reduction in several randomized trials, and ALCAR has shown some benefit in smaller studies, though the data are thinner.
No major medical organization recommends alpha lipoic acid or acetyl L-carnitine as a first-line treatment for neuropathy, and neither supplement replaces prescribed care.
Energy, fatigue, and exercise
Claims about better workouts and less fatigue are mostly based on the supplements' roles in energy metabolism rather than on consistent trial results. Studies in healthy adults have produced mixed findings.
Dosage, Forms, and Timing
There is no official recommended daily allowance for either compound, and doses used in research are higher than what most people get from food.
- ALA: 300 to 600 mg per day is a common starting range; neuropathy trials have used up to 1,800 mg per day under medical supervision.
- ALCAR: 1,000 to 2,000 mg per day, often split into two doses of 500 to 1,000 mg.
- Timing: ALA is usually taken on an empty stomach for better absorption, and ALCAR is often taken in the morning because some users find it stimulating.
- Form: If you choose ALA, R-ALA or sodium R-lipoate may be more potent per milligram than a racemic mix.
Some people use acetyl l carnitine with alpha lipoic acid in a single capsule for convenience, but a combined product makes it harder to adjust each dose separately.
Choosing a quality product
- Third-party testing: Look for USP, NSF International, or Informed Choice seals so you know the label matches the contents.
- Transparent doses: Skip proprietary blends so you can see exactly how much of each ingredient you get.
- Storage: ALA degrades with heat and light, so keep it in a cool, dry place with the lid tight.
Safety, Side Effects, and Interactions
Both supplements are generally well tolerated at typical doses, but natural does not mean risk-free.
- Blood sugar: ALA can lower blood glucose, which may cause hypoglycemia when combined with insulin or sulfonylureas.
- Thyroid medication: ALA and ALCAR have both been reported to interfere with thyroid hormone levels or levothyroxine absorption; separate doses by at least four hours and tell your prescriber.
- Bleeding risk: ALA may have mild antiplatelet effects in theory, so caution is reasonable with warfarin or other blood thinners.
- GI effects: Nausea, vomiting, and diarrhea are the most common complaints, especially at higher ALA doses.
- Pregnancy and nursing: Safety data are insufficient, so these supplements are usually avoided.
Alpha lipoic acid and acetyl L-carnitine are not FDA-approved to treat or prevent any disease. Talk with a healthcare professional before starting them, especially if you take prescription medication or have diabetes, thyroid disease, or a seizure disorder.
If you and your clinician decide the pair is worth trying, start at the low end of the dose range and give it several weeks before judging whether it helps. Buy from a reputable brand and recheck your medication list for interactions.
Frequently Asked Questions
Can you take alpha lipoic acid and acetyl L-carnitine together?
Yes, the two are commonly stacked in research and in commercial combination products. Human studies have used roughly 600 to 1,000 mg of alpha lipoic acid and 1,000 to 2,000 mg of acetyl L-carnitine per day, often split into two doses. Check with a healthcare professional first if you take diabetes medication, thyroid hormones, or blood thinners.
What is the best time to take alpha lipoic acid and acetyl L-carnitine?
ALA is usually taken on an empty stomach, about 30 minutes before a meal, because food reduces its absorption. ALCAR is often taken in the morning or split into two doses earlier in the day since some users find it stimulating. Consistency matters more than a perfect clock time, so pick a schedule you can keep.
Does alpha lipoic acid with acetyl L-carnitine help neuropathy or memory?
The best evidence for this pair is for alpha lipoic acid in diabetic peripheral neuropathy, where intravenous ALA is an approved treatment in Germany. Memory trials using the combination have been small and mixed, with some showing slower decline and others showing no difference from placebo. Neither supplement is FDA-approved to treat neuropathy, Alzheimer's disease, or any other condition.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.